Opportunities for India’s Pharma Supply Chain post COVID19 | 21st May 2020
Opportunities for India’s Pharma Supply Chain post COVID19 | 21st May 2020
The COVID-19 pandemic has highlighted vulnerabilities in the Pharma manufacturing supply chain and India’s over-reliance on China as a global ingredient producer of APIs. As we adjust our supply chains to the new normal, we need to ensure that we can create alternative supply arrangements without compromising on quality, reduce potential disruption, and boost our technology infrastructure to prepare for the future.
Through this webinar, get to explore the following areas:
- Challenges & opportunities post COVID-19
- India’s role in the pharma supply chain
- Implementing the “China-plus-one” policy
- Adapting Pharma’s supply chain to the new normal
Speakers
Amandeep Singh Bhan
SVP – Enterprise Business
Abheet Dwivedi
Director – Strategic PartnershipsCOVID-19: Managing Supply Chain Disruptions | 23rd April 2020
COVID-19: Managing Supply Chain Disruptions | 23rd April 2020
Watch this webinar to explore strategies to manage supply chain disruptions in response to the COVID-19 crisis and learn from our supply chain expert how enterprises are re-tooling their production systems in the short-term to meet the evolving customer needs. You can watch the webinar recording on this page.
Through the webinar, our speaker will cover the following areas:
- Impact on global supply chain
- Impact on different sectors of the Indian economy
- How companies including Moglix are fighting back
- Strategies for managing supply chain disruptions
Speaker
Partha Dash
Senior Vice PresidentMoglix Business
Back